EX-10.11 15 a2238822zex-10_11.htm EX-10.11 HIGHLY CONFIDENTIAL EXECUTION VERSION [***] Certain information in this document, marked by brackets, has been excluded pursuant to Item 601(b)(10)(iv) of Regulation S-K under the Securities Act of 1933, as...Co-Development and Collaboration Agreement • May 5th, 2020
Contract Type FiledMay 5th, 2020This Amendment No. 5 (this “Amendment No. 5”) to the Current Agreement (as defined below) is made as of January 22, 2018 (the “Amendment Effective Date”)
AMENDMENT NO. 5 TO CO-DEVELOPMENT AND COLLABORATION AGREEMENTCo-Development and Collaboration Agreement • May 28th, 2019 • Genmab a/S • Pharmaceutical preparations
Contract Type FiledMay 28th, 2019 Company IndustryThis Amendment No. 5 (this “Amendment No. 5”) to the Current Agreement (as defined below) is made as of January 22, 2018 (the “Amendment Effective Date”)
AMENDMENT NO. 5 TO CO-DEVELOPMENT AND COLLABORATION AGREEMENTCo-Development and Collaboration Agreement • April 2nd, 2019 • Genmab a/S • Pharmaceutical preparations
Contract Type FiledApril 2nd, 2019 Company IndustryThis Amendment No. 5 (this “Amendment No. 5”) to the Current Agreement (as defined below) is made as of January 22, 2018 (the “Amendment Effective Date”)